Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.620
+0.030 (0.65%)
At close: Nov 21, 2025, 4:00 PM EST
4.440
-0.180 (-3.90%)
After-hours: Nov 21, 2025, 7:17 PM EST
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $261.27 million as of November 21, 2025. Its market cap has decreased by -49.14% in one year.
Market Cap
261.27M
Enterprise Value
103.52M
1-Year Change
-49.14%
Ranking
Category
Stock Price
$4.62
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $261.27M, a decrease of -53.79%. That is a compound annual growth rate of -14.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 261.27M | -0.43% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |